2010: Johnson & Johnson commits $200 million over the next 5 years for a package of commitments called ‘Every Mother, Every Child’ that aims to help as many as 120 million women and children each year. Every Mother, Every Child aims to increase life expectancy and quality-of-life for women and children in the developing world. Johnson & Johnson is committed to providing more than 15 million expectant and new mothers in Bangladesh, China, India, Mexico, Nigeria, and South Africa with free mobile phone messages on prenatal health, reminders of clinic appointments and calls from health mentors over the five-year program. Johnson & Johnson will also donate 200 million doses, each year, of mebendazole, a treatment for intestinal worms in children. Johnson & Johnson is also committed to researching and developing a drug for tuberculosis with a new mechanism of action in 40 years, antiretrovirals to treat HIV and potentially prevent HIV transmission from pregnant women to their infants, as well as new technologies that may, in the future, prevent the transmission of HIV between adults. Johnson & Johnson is also committed to extending current commitments to peer education programs that have been successful in preventing mother-to-child transmission of HIV; reducing a life-threatening condition in infants caused by lack of oxygen at birth (birth asphyxia); and upgrading existing health care facilities to accommodate more women at risk of fistulas.

By researching and developing a drug for tuberculosis with new mechanism of action in new technologies. Johnson and Johnson will also commit to its peer education programs in preventing mother-to-child transmission of HIV.